Tyndall Formulation Services, LLC is a contract research company that specializes in developing new drug delivery technologies and applications for poorly water soluble drugs, with an emphasis in oncology. Our company founder Kevin Sill, Ph.D., has taken an idea from concept to clinical use, and the Tyndall Formulations team has decades of experience in research, chemistry, clinical development and executive leadership. We have the expertise to guide our partners with everything from preclinical development, drug delivery and intellectual property, to manufacturing, fundraising and gaining regulatory support of products.